Hebebrand, J., Hinney, A., Knoll, N., Volckmar, A
Moreover, combination therapies have demonstrated significant advantages, such as Novo Nordisks CagriSema (semaglutide + cagrilintide), which shows superior glycemic control and weight reduction effects compared to semaglutide alone, demonstrating that combination therapy can achieve more than the sum of its parts while reducing side effects.117 Additionally, to improve patient compliance, it is crucial to extend the drugs half-life
The information provided is for educational reference and does not represent medical advice, dosing recommendations, or guidance for human or animal use.
Using evidence-based strategies like goal setting, mindfulness, and personalized nutrition planning, RDNs empower individuals to develop habits that support long-term success